LivaNova (LIVN) Other Gross PP&E Adjustments (2015 - 2026)
LivaNova's (LIVN) quarterly Other Gross PP&E Adjustments came in at -$54.5 million in Q1 2026, down 13.23% year-on-year from -$62.8 million in Q1 2025, and down 112.7% quarter-over-quarter from $429.3 million in Q4 2025.
LivaNova (LIVN) Other Gross PP&E Adjustments (2015 - 2026) Analysis & Trends
LivaNova has disclosed Other Gross PP&E Adjustments across 12 years of filings, most recently posting -$54.5 million for Q1 2026.
- Other Gross PP&E Adjustments for Q1 2026 came in at -$54.5 million, down 13.23% year-over-year; the trailing twelve-month figure through Mar 2026 was -$54.5 million (down 13.23% YoY), and the FY2025 annual result was $429.3 million, up 30.02% from the prior year.
- Other Gross PP&E Adjustments came in at -$54.5 million for Q1 2026 at LivaNova, down from $429.3 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $429.3 million in Q4 2025 to a low of -$54.5 million in Q1 2026.
- The 5-year median for Other Gross PP&E Adjustments is -$38.2 million (2022), against an average of $45.6 million.
- Across the five-year window, Other Gross PP&E Adjustments plunged 63.63% in 2024 and jumped 30.02% in 2025, its largest moves.
- LivaNova's Other Gross PP&E Adjustments stood at $286.5 million in 2022, then climbed by 4.5% to $299.4 million in 2023, then grew by 10.29% to $330.2 million in 2024, then jumped by 30.02% to $429.3 million in 2025, then slumped by 112.7% to -$54.5 million in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$54.5 million (Q1 2026), $429.3 million (Q4 2025), and -$51.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 23.14 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -405.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -547.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -99.30 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 5.30 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 2.39 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 991.00 Mn |
| 10 | LivaNova | 4.34 Bn | 3.76 Bn | 243.75 Mn | -54.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -54.53 Mn |
| Mar 31, 2026 | -54.53 Mn |
| Dec 31, 2025 | 429.29 Mn |
| Dec 31, 2025 | 429.29 Mn |
| Sep 30, 2025 | -51.20 Mn |
| Sep 30, 2025 | -51.20 Mn |
| Jun 30, 2025 | -50.68 Mn |
| Jun 30, 2025 | -50.68 Mn |
| Mar 31, 2025 | -48.16 Mn |
| Mar 31, 2025 | -48.16 Mn |
| Dec 31, 2024 | 330.18 Mn |
| Dec 31, 2024 | 330.18 Mn |
| Sep 30, 2024 | -51.60 Mn |
| Sep 30, 2024 | -51.60 Mn |
| Jun 30, 2024 | -49.74 Mn |
| Jun 30, 2024 | -49.74 Mn |
| Mar 31, 2024 | -50.26 Mn |
| Mar 31, 2024 | -50.26 Mn |
| Dec 31, 2023 | 299.37 Mn |
| Dec 31, 2023 | 299.37 Mn |